Le Lézard
Classified in: Health, Business
Subjects: TDS, WOM, JVN

Dignitana, Inc. to Sponsor Susan G. Komen® Events in Dallas, New York and Los Angeles


DALLAS, Feb. 14, 2020 /PRNewswire-PRWeb/ -- Dignitana AB, world leader in scalp cooling innovation, announced today that its U.S. subsidiary, Dignitana, Inc., has signed on to sponsor three signature events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana's reach to hundreds of thousands of participants in the Susan G. Komen Race for the Cure® and MORE THAN PINK Walk® events in key Dignitana markets throughout year.

Dignitana is a proud supporter of Susan G. Komen and their mission to save lives by meeting the most critical needs in communities and investing in breakthrough research to prevent and cure breast cancer.

"As the world's leading nonprofit breast cancer organization, Susan G. Komen launched a movement that has made a worldwide impact in the fight against breast cancer," says William Cronin, CEO of Dignitana. "We are honored to support Susan G. Komen and the important work they do from the community level up."

The Susan G. Komen Race for the Cure® Series is the world's largest and most successful education and fundraising event for breast cancer ever created. It celebrates breast cancer survivorship and honors those who have lost their battle with the disease. Komen's MORE THAN PINK Walk® brings together an empowered community of hope to raise funds for breast cancer treatment, patient advocacy and lifesaving research.

"Susan G. Komen remains committed to the fight against breast cancer, taking every step we can toward our mission of saving lives and supporting those affected by breast cancer," says Carrie Stovall, Vice President, Fundraising and Events at Susan G. Komen. "We are so grateful for supporters like Dignitana and look forward to seeing the impact our partnership will make."

The alliance kicks off this month with the Susan G. Komen MORE THAN PINK Walk® Los Angeles County on February 29 at Dodger Stadium in Los Angeles, California and will be followed by the prestigious Susan G. Komen Race for the Cure® Greater New York City on September 13. For Breast Cancer Awareness Month in October, the sponsorship will be in Dignitana, Inc.'s "backyard," with the Susan G. Komen MORE THAN PINK Walk® Dallas County held on October 24 at the North Park Center in Dallas, Texas.

Since its founding, Komen has funded more than $1 billion in research and invested more than $2.3 billion to provide screening, diagnostics, education, treatment and psychosocial support to people in communities across the U.S. and in 60 countries worldwide.

Join Team DigniCap today! Sign Up Here to walk with Dignitana at the Susan G. Komen MORE THAN PINK Walk® on February 29 in Los Angeles.

About Dignitana Inc.
Dignitana, Inc. is a subsidiary of Dignitana AB, the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at http://www.dignitana.se and http://www.dignicap.com.

Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 certifiedadviser@penser.se http://www.penser.se

About Susan G. Komen®
Susan G. Komen® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

 

SOURCE Dignitana, Inc.


These press releases may also interest you

at 07:55
A dedicated and passionate oral surgeon, Dr. Michael Noffze is eager to announce that his practice has fully reopened to existing and new patients. With previously limited access during the coronavirus pandemic, this surgical team is excited to...

at 07:45
The "Funeral Services and Related Activities in South Africa 2020" report has been added to ResearchAndMarkets.com's offering. This report focuses on South Africa's funeral services industry, including information on the size and state of the sector,...

at 07:45
Drs. Michael Klein and Allon Waltuch are now accepting new patients with or without a referral for transformative full mouth reconstruction treatment in Cedarhurst, NY and the surrounding Five Towns area. This treatment rejuvenates the smiles of...

at 07:35
Titan Medical Inc. ("Titan" or "Titan Medical") , a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a development and license agreement with Medtronic plc...

at 07:35
Full analysis of the CLE part of the LILAC study reinforces positive top-line results; participants who received BIIB059 (anti-BDCA2) demonstrated statistically significant reduction of disease activity compared to those who received placeboSafety...

at 07:30
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") , a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced it is collaborating, pursuant to an agreement dated May 14, 2020, in a...



News published on 14 february 2020 at 08:00 and distributed by: